BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 27531900)

  • 1. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma.
    Chen Y; Kuang D; Zhao X; Chen D; Wang X; Yang Q; Wan J; Zhu Y; Wang Y; Zhang S; Wang Y; Tang Q; Masuzawa M; Wang G; Duan Y
    Oncotarget; 2016 Sep; 7(36):58148-58161. PubMed ID: 27531900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
    Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
    Zhang Y; Feng Y; Chen L; Zhu J
    Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.
    Sun KX; Chen Y; Chen S; Liu BL; Feng MX; Zong ZH; Zhao Y
    Oncotarget; 2016 Feb; 7(8):9236-49. PubMed ID: 26843615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.
    Zhang X; Zhang Y; Yang J; Li S; Chen J
    Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z; Zhang W; Mao J; Xu Z; Fan M
    Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis.
    Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ
    World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-195-5p, a new regulator of Fra-1, suppresses the migration and invasion of prostate cancer cells.
    Wu J; Ji A; Wang X; Zhu Y; Yu Y; Lin Y; Liu Y; Li S; Liang Z; Xu X; Zheng X; Xie L
    J Transl Med; 2015 Sep; 13():289. PubMed ID: 26337460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
    Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
    Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
    Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
    Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
    Liu Y; Liang G; Wang H; Liu Z
    Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.